The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2021/03/31
-
Journal
-
Indian UGC (journal)
-
Refrences223
-
Citations208
-
Alessandra Spada Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta T6G 1Z2, CanadaDIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin 10129, ItalyFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2R3, Canada
-
Jaber Emami Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2R3, CanadaDepartment of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
-
Jack A. Tuszynski Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta T6G 1Z2, CanadaDIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin 10129, Italy ORCID
-
Afsaneh Lavasanifar Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2R3, Canada ORCID
Cite
Spada, Alessandra, et al. “The Uniqueness of Albumin As a Carrier in Nanodrug Delivery”. Molecular Pharmaceutics, vol. 18, no. 5, 2021, pp. 1862-94, https://doi.org/10.1021/acs.molpharmaceut.1c00046.
Spada, A., Emami, J., Tuszynski, J. A., & Lavasanifar, A. (2021). The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Molecular Pharmaceutics, 18(5), 1862-1894. https://doi.org/10.1021/acs.molpharmaceut.1c00046
Spada A, Emami J, Tuszynski JA, Lavasanifar A. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Molecular Pharmaceutics. 2021;18(5):1862-94.
Journal Categories
Medicine
Medicine (General)
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- Micellar Nanocarriers: Pharmaceutical Perspectives
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates
- Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems
- Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Preparation, characterization, and antiproliferative activities of biotin-decorated docetaxel-loaded bovine serum albumin nanoparticles | Brazilian Journal of Pharmaceutical Sciences |
| 8 | 2018 |
| 10.1158/1538-7445.AM2016-2076 | Cancer Research |
| 2016 | |
Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine | Journal of Nanomaterials |
| 469 | 2019 |
| Underlying the Mechanism of 5-Fluorouracil and Human Serum Albumin Interaction: A Biophysical Study | Journal of Physical Chemistry & Biophysics | 17 | 2016 | |
| Evaluation of nano spray drying as a method for drying and formulation of therapeutic peptides and proteins | Frontiers in Pharmacology |
| 44 | 2015 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Synthesis and characterization of novel Ru(III) complexes of 2‐aminopyrazine: Interaction with biomolecules, antineoplastic activity, and computational investigation | Applied Organometallic Chemistry |
| 2024 | |
A Facile Access to Green Fluorescent Albumin Derivatives | ChemBioChem |
| 2024 | |
A Practical, Scalable Synthesis of 1,18‐Octadecanedioic acid‐Paclitaxel (ODDA‐PTX) | European Journal of Organic Chemistry |
| 2024 | |
| The influence of sugar molecule type on the stability of lyophilized human serum albumin (HSA) nanocolloid kit | Journal of Radioanalytical and Nuclear Chemistry |
| 2024 | |
| Celastrol-loaded bovine serum albumin nanoparticles target inflamed neutrophils for improved rheumatoid arthritis therapy | Acta Biomaterialia |
| 2024 |
Citations Analysis
The category
Science: Chemistry 91
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Bovine Serum Albumin-Encapsulated Ultrasmall Gold Nanoclusters for Photodynamic Therapy of Tumors and was published in 2021. The most recent citation comes from a 2024 study titled Long-Circulating Vasoactive 1,18-Octadecanedioic Acid–Terlipressin Conjugate. This article reached its peak citation in 2023, with 106 citations. It has been cited in 125 different journals, 24% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 11 citations. The chart below illustrates the annual citation trends for this article.